Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes
Clinical trial NCT05524974 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05524974
- Sponsor
- Fujian Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.